915 / 1119
Learning Objectives I
•
Know about typical late morbidity patterns for
rectum, bladder, bowel and vagina after IGABT
for cervix cancer combined with radio-
chemotherapy;
•
Know about typical mid and long term
impairments in quality of life (functional
aspects in daily life and patient reported
symptoms) after IGABT for cervix cancer
combined with radio-chemotherapy;